(R)-ACX, a pancreatic β-cell selective sulfonylurea, does not aggravate myocardial ischemia-reperfusion damage

European Journal of Pharmacology

Volumn 577, Issue 1-3, 2007, Pages 211-218

  Namekata, Iyuki ^a   Yamaguchi, Yusuke ^a   Moriguchi, Shuhei ^a   Yamazaki, Satoshi ^a   Terasawa, Akihiko ^a   Yamagishi, Reiko ^a   Aikawa, Tokiko ^a   Saito, Tomoaki ^a   Kurashima, Katsumi ^b   Seri, Kenji ^b   Imamura, Yorishige ^c   Akita, Hiroyuki ^a   Shigenobu, Koki ^a   Tanaka, Hikaru ^a  

^a TOHO UNIVERSITY   (Japan)

^b Central Research Laboratory   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

(R) ACX; Heart; Ischemia reperfusion

Indexed keywords

7,8 DIHYDRO 7 HYDROXY 6,6 DIMETHYL 8 (2 OXO 1 PIPERIDYL) 6H PYRANO[2,3 F][2,1,3]BENZOXADIAZOLE; ACETOXYHEXAMIDE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; AMIDE; GLIBENCLAMIDE; NORADRENALIN; SULFONYLUREA; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; DRUG POTENCY; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE ISCHEMIA; INSULIN RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TISSUE PREPARATION; VASCULAR RING;

ACTION POTENTIALS; ANIMALS; BENZOPYRANS; CELLS, CULTURED; FEMALE; GLYBURIDE; GUINEA PIGS; HYPOGLYCEMIC AGENTS; INSULIN-SECRETING CELLS; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; PAPILLARY MUSCLES; RATS; SULFONYLUREA COMPOUNDS;

EID: 35548983423     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.09.012     Document Type: Article

References (47)

1. Akita H., Kurashima K., Nozawa M., Yamamura S., Seri K., and Imamura Y. Determination of absolute configuration of a metabolite (-)-hydroxyhexamide from acetohexamide, syntheses of (-)- and (+)-hydroxyhexamides and (-)- and (+)-acetoxyhexamides. Tetrahedron: Asymmetry 9 (1998) 4331-4340
2. Asfari M., Janjic D., Meda P., Li G., Halban P.A., and Wollheim C.B. Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130 (1992) 167-178
3. Ashfield R., Gribble F.M., Ashcroft S.J., and Ashcroft F.M. Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel. Diabetes 48 (1999) 1341-1347
4. Bollheimer L.C., Wrede C.E., Rockmann F., Ottinger I., Scholmerich J., and Buettner R. Glucagon production of the rat insulinoma cell line INS-1-a quantitative comparison with primary rat pancreatic islets. Biochem. Biophys. Res. Commun. 330 (2005) 327-332
5. 2+ loading in cardiomyocytes. Eur. J. Pharmacol. 308 (1996) 343-349
6. ATP channels. FASEB J. 18 (2004) 1046-1048
7. ATP channel. Annu. Rev. Physiol. 62 (2000) 79-109
8. + channels protect the myocardium against ischemia/reperfusion damage. Circ. Res. 69 (1991) 571-581
9. + ATP channels in coronary vasodilation during exercise. Circulation 88 (1993) 1245-1253
10. Ferdinandy P., Szilvássy Z., Droy-Lefaix M.T., Tarrade T., and Koltai M. KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide. Cardiovasc. Res. 30 (1995) 781-787
11. Fisman E.Z., Tenenbaum A., Motro M., and Adler Y. Oral antidiabetic therapy in patients with heart disease. A cardiologic standpoint. Herz. 29 (2004) 290-298
12. Garratt K.N., Brady P.A., Hassinger N.L., Grill D.E., Terzic A., and Holmes Jr. D.R. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J. Am. Coll. Cardiol. 33 (1999) 119-124
13. Grover G.J., Dzwonczyk S., Sleph P.G., and Sargent C.A. The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts. J. Pharmacol. Exp. Ther. 265 (1993) 559-564
14. Inagaki N., and Seino S. ATP-sensitive potassium channels: structures, functions, and pathophysiology. Jpn. J. Physiol. 48 (1998) 397-412
15. Jennings A., Wilson R., and Ward J. Symptomatic hypoglycemia NIDDM patients treated with oral hypoglycemic agents. Diabetes Care 12 (1989) 203-208
16. Kato Y., Masumiya H., Agata N., Tanaka H., and Shigenobu K. Developmental changes in action potential and membrane currents in fetal, neonatal and adult guinea-pig ventricular myocytes. J. Mol. Cell. Cardiol. 28 (1996) 1515-1522
17. Kecskemeti V., Bagi Z., Pacher P., Posa I., Kocsis E., and Koltai M.Z. New trends in the development of oral antidiabetic drugs. Curr. Med. Chem. 9 (2002) 53-71
18. Klepzig H., Kober G., Matter C., Luus H., Schneider H., Boedeker K.H., Kiowski W., Amann F.W., Gruber D., Harris S., and Burger W. Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide. Eur. Heart J. 20 (1999) 439-446
19. Knatterud G.L., Klimt C.R., Levin M.E., Jacobson M.E., and Goldner M.G. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment. JAMA 240 (1978) 37-42
20. ATP channels in mouse isolated pancreatic β cells but not rat heart or arterial smooth muscle cells. Diabetologia 44 (2001) 1019-1025
21. Lim K.H., Javadov S.A., Das M., Clarke S.J., Suleiman M.S., and Halestrap A.P. The effects of ischaemic preconditioning, diazoxide and 5-hydroxydecanoate on rat heart mitochondrial volume and respiration. J. Physiol. 545 (2002) 961-974
22. Maddock H.L., Siedlecka S.M., and Yellon D.M. Myocardial protection from either ischaemic preconditioning or nicorandil is not blocked by gliclazide. Cardiovasc. Drugs Ther. 18 (2004) 113-119
23. Masuda Y., Arakawa C., Yamashita T., Miyajima M., Shigenobu K., Kasuya Y., and Tanaka S. Potassium channel opening properties of a novel compound, NIP-121, cromakalim and nicorandil in rat aorta and portal vein. Eur. J. Pharmacol. 195 (1991) 323-331
24. + channel opening properties of a novel compound, NIP-121, in guinea pig myocardium as compared with those of cromakalim. J. Cardiovasc. Pharmacol. 26 (1995) 608-613
25. Meinert C.L., Knatterud G.L., Prout T.E., and Klimt C.R. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes 19 (1970) 789-830
26. Nagashima K., Takahashi A., Ikeda H., Hamasaki A., Kuwamura N., Yamada Y., and Seino Y. Sulfonylurea and non-sulfonylurea hypoglycemic agents: pharmachological properties and tissue selectivity. Diabetes Res. Clin. Pract. 66 (2004) S75-S78
27. 2+ exchanger, during ischemia and reperfusion in guinea-pig myocardium. Life Sci. 77 (2005) 312-324
28. 2+ overload. Eur. J. Pharmacol. 543 (2006) 108-115
29. Ohnota H., Koizumi T., Tsutsumi N., Kobayashi M., Inoue S., and Sato F. Novel rapid- and short-acting hypoglycemic agent, a calcium (2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinycarbonyl)propionate (KAD-1229) that acts on the sulfonylurea receptor: comparison of effects between KAD-1229 and gliclazide. J. Pharmacol. Exp. Ther. 269 (1994) 489-495
30. Ohta T., Furukawa N., Yonemori F., and Wakitani K. JTT-608 controls blood glucose by enhancement of glucose-stimulated insulin secretion in normal and diabetic mellitus rats. Eur. J. Pharmacol. 367 (1999) 91-99
31. O'Rourke B. Pathophysiological and protective roles of mitochondrial ion channels. J. Physiol. 529 (2000) 23-36
32. + channels and their role in cardioprotection. Circ. Res. 94 (2004) 420-432
33. Pogatsa G., Koltai Z.M., and Ballagi-Pordany G. Influence of hypoglycemic sulfonylurea compounds on the incidence of ventricular ectopic beats in non-insulin-dependent diabetic patients treated with digitalis. Curr. Ther. Res. 53 (1993) 329-339
34. Qian Y.Z., Levasseur J.E., Yoshida K., and Kukreja R.C. KATP channels in rat heart: blockade of ischemic and acetylcholine-mediated preconditioning by glibenclamide. Am. J. Physiol. 271 (1996) H23-H28
35. Saito W., Noguchi K., Okazaki K., Matsuda T., Kato Y., Tanaka H., and Shigenobu K. Temperature-sensitive effects of potassium channel openers on isolated guinea pig myocardium and aorta. J. Cardiovasc. Pharmacol. 31 (1998) 327-329
36. Scognamiglio R., Avogaro A., Vigili de Kreutzenberg S., Negut C., Palisi M., Bagolin E., and Tiengo A. Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial dysfunction in type 2 diabetes. Diabetes 51 (2002) 808-812
37. Seri K., Sanai K., Kurashima K., Imamura Y., and Akita H. (R)-ACX is a novel sufonylurea compound with potent, quick and short-lasting hypoglycemic activity. Eur. J. Pharmacol. 389 (2000) 253-256
38. Tanaka H., Matsui S., Kawanishi T., and Shigenobu K. Use of chloride blockers: a novel approach for cardioprotection against ischemia-reperfusion damage. J. Pharmacol. Exp. Ther. 278 (1996) 854-861
39. Tanaka H., Okazaki K., and Shigenobu K. Cardioprotective effects of NIP-121, a novel ATP sensitive potassium channel opener, during ischemia and reperfusion in coronary perfused guinea pig myocardium. J. Cardiovasc. Pharmacol 27 (1996) 695-701
40. 2+ current. Naunyn-Schmiedeberg's Arch. Pharmacol. 356 (1997) 853-855
41. Tanaka H., Matsui S., and Shigenobu K. Cardioprotective effects of beraprost sodium against experimental ischemia and reperfusion as compared with propranolol and diltiazem. Res. Commun. Mol. Pathol. Pharmacol 99 (1998) 321-327
42. The UKPDS Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352 (1998) 854-865
43. Thornton J.D., Thornton C.S., Sterling D.L., and Downey J.M. Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts. Circ. Res. 72 (1993) 44-49
44. Toombs C.F., McGee S., Johnston W.E., and Vinten-Johansen J. Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation 86 (1992) 986-994
45. Yamashita T., Masuda Y., and Tanaka S. Inhibitory properties of NIP-121, a potassium channel opener, on high potassium- and norepinephrine-induced contraction and calcium mobilization in rat aorta. J. Cardiovasc. Pharmacol. 24 (1994) 890-895
46. Yamashita T., Masuda Y., and Tanaka S. Potassium channel openers relax A23187-induced nifedipine-resistant contraction of rat aorta. J. Cardiovasc. Pharmacol. 24 (1994) 914-920
47. + channels in pancreatic, cardiac, and vascular smooth muscle cells. Am. J. Physiol. 274 (1998) C25-C37